Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity

European Neuropsychopharmacology

Volumn 21, Issue 6, 2011, Pages 450-456

  Caputo, Fabio ^a,b   Francini, Sara ^a   Brambilla, Romeo ^c   Vigna Taglianti, Federica ^c,d   Stoppo, Michela ^a   Del Re, Arfedele ^e   Leggio, Lorenzo ^f,g   Addolorato, Giovanni ^g   Zoli, Giorgio ^b   Bernardi, Mauro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SS Annunziata Hospital   (Italy)

^c Piedmont Centre for Drug Addiction Epidemiology   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

^e ASL Bologna   (Italy)

^f BROWN UNIVERSITY   (United States)

^g CATHOLIC UNIVERSITY   (Italy)

Author keywords

Alcohol pharmacotherapy; Alcohol dependence; Craving for and abuse of sodium oxybate; Psychiatric co morbidity; Sodium oxybate

Indexed keywords

ALCOHOL; OXYBATE SODIUM;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; COMORBIDITY; DRUG ABUSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; SIDE EFFECT; TREATMENT OUTCOME; VERTIGO; WITHDRAWAL SYNDROME;

ALCOHOL DETERRENTS; ALCOHOLICS; ALCOHOLISM; BIOMARKERS, PHARMACOLOGICAL; COMORBIDITY; ETHANOL; FEMALE; GABA AGENTS; HUMANS; MALE; MENTAL DISORDERS; RECURRENCE; SODIUM OXYBATE; SUBSTANCE WITHDRAWAL SYNDROME; TEMPERANCE; TREATMENT OUTCOME;

EID: 79955645913     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.12.005     Document Type: Article

References (35)

1. Addolorato G., Leggio L., Ferrulli A., Caputo F., Gasbarrini A. The therapeutic potential of gamma-hydroxybutyric acid for alcohol dependence: balancing the risks and benefits. A focus on clinical data. Expert Opin. Investig. Drugs 2009, 18:675-686.
2. Agabio R., Colombo G., Loche A., Lobina C., Pani M.L., Reali R., Gessa G.L. Gamma-hydroxybutyric acid reducing effect on ethanol intake: evidence in favour of a substitution mechanism. Alcohol Alcohol. 1998, 33:465-474.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Text Revision, Washington DC. 4th ed.
4. Bornovalova M.A., Lejuez C.W., Daughters S.B., Rosenthal Z.M., Lynch T.R. Impulsivity as a common process across borderline personality and substance use disorders. Clin. Psychol. Rev. 2005, 25:790-812.
5. Caputo F., Bernardi M. Medications acting on the GABA system in the treatment of alcoholic patients. Curr. Pharm. Des. 2010, 16:2118-2125.
6. Caputo F., Addolorato G., Lorenzini F., Domenicali M., Greco G., Del Re A., Gasbarrini G., Stefanini G.F., Bernardi M. Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. Drug Alcohol Depend. 2003, 70:85-91.
7. Caputo F., Vignoli T., Maremmani I., Bernardi M., Zoli G. Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review. Int. J. Environ. Res. Public Health 2009, 6:1917-1929.
8. Caputo F., Francini S., Stoppo M., Lorenzini F., Vignoli T., Del Re A., Comaschi C., Leggio L., Addolorato G., Zoli G., Bernardi M. Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study. J. Psychopharmacol. 2009, 23:883-890.
9. Casillas A., Clark L.A. Dependency, impulsivity, and self-harm: traits hypothesized to underlie the association between cluster B personality and substance use disorders. J. Personal. Disord. 2002, 16:424-436.
10. Centers for Disease Prevention Control (CDC) Cigarette smoking among adults-United States, 1999, MMWR. Morb. Mortal. Wkly Rep. 2001, 50:869-873.
11. Colombo G., Agabio R., Lobina C., Reali R., Fadda F., Gessa G.L. Cross-tolerance to ethanol and gamma-hydroxybutyric acid. Eur. J. Pharmacol. 1995, 273:235-238.
12. Conway K.P., Compton W., Stinson F.S., Grant B.F. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J. Clin. Psychiatry 2006, 67:247-257.
13. Dawe S., Gullo M.J., Loxton N.J. Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict. Behav. 2004, 29:1389-1405.
14. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. gamma-Hydroxybutyric acid in the treatment of alcohol dependence: a double-blind study. Alcohol. Clin. Exp. Res. 1992, 16:673-676.
15. Gessa G.L., Agabio R., Carai M., Lobina C., Pani M., Reali R., Colombo G. Mechanism of the anti-alcohol effect of gamma-hydroxybutyric acid (GHB). Alcohol 2000, 20:271-276.
16. Gobaille S., Schleef C., Hechler V., Viry S., Aunis D., Maitre M. Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain. Life Sci. 2002, 70:2101-2112.
17. Grant B.F., Stinson F.S., Dawson D.A., Chou S.P., Dufour M.C., Compton W., Pickering R.P., Kaplan K. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch. Gen. Psychiatry 2004, 61:807-816.
18. Hesse S., Barthel H., Schwarz J., Sabri O., Müller U. Advances in vivo imaging of serotonergic neurons in neuropsychiatric disorders. Neurosci. Biobehav. Rev. 2004, 28:547-563.
19. Kessler R.C. The epidemiology of dual diagnosis. Biol. Psychiatry 2004, 56:730-737.
20. Le Fauve C.E., Litten R.Z., Randall C.L., Moak D.H., Salloum I.M., Green A.L. Pharmacological treatment of alcohol abuse/dependence with psychiatric comorbidity. Alcohol. Clin. Exp. Res. 2004, 28:302-312.
21. Lehert P. Review and discussion of statistical analysis of controlled clinical trials in alcoholism. Alcohol Alcohol. 1993, 28:157-163.
22. Leone M.A., Vigna-Taglianti F.D., Avanzi G.C., Brambilla R., Faggiano F. Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses. Cochrane Database Syst. Rev. 2010, 17(2):CD006266.
23. Lesch K.P. Alcohol dependence and gene x environment interaction in emotion regulation: is serotonin the link?. Eur. J. Pharmacol. 2005, 526:113-124.
24. Lieb K., Vollm B., Rucker G., Timmer A., Stoffers J.G. Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials. Br. J. Psychiatry 2010, 196:4-12.
25. O'Connor P.G., Schottenfeld R.S. Patients with alcohol problems. N. Engl. J. Med. 1998, 338:592-602.
26. O'Malley S.S., Jaffe A.J., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch. Gen. Psychiatry 1992, 49:881-887.
27. Pardi D., Black J. gamma-Hydroxybutyrate/GHB: neurobiology, and impact on sleep and wakefulness. CNS Drugs 2006, 20:993-1018.
28. Petrakis I.L., Poling J., Levinson C., Nich C., Carroll K., Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid psychiatric disorders. Biol. Psychiatry 2005, 57:1128-1137.
29. Petrakis I.L., Poling J., Levinson C., Nich C., Carroll K., Ralevski E., Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and comorbid post-traumatic stress disorder. Biol. Psychiatry 2006, 60:777-783.
30. Petrakis I., Ralevski E., Nich C., Levinson C., Carroll K., Poling J., Rounsaville B. Naltrexone and disulfiram in patients with alcohol dependence and current depression. J. Clin. Psychopharmacol. 2007, 27:160-165. VA VISN I MIRECC Study Group.
31. Queyen Q.T., Mausbach B. Treatments for patients with dual diagnosis: a review. Alcohol. Clin. Exp. Res. 2007, 31:513-536.
32. Ralevski E., Ball S., Nich C., Limoncelli D., Petrakis I. The impact of personality disorders on alcohol-use outcomes in a pharmacotherapy trial for alcohol dependence and comorbid Axis I disorders. Am. J. Addictions. 2007, 16:443-449.
33. Ricaurte G.A., McCann U.D. Recognition and management of complications of new recreational drug use. Lancet 2005, 365:2137-2145.
34. Snead O.C.I.I.I., Gibson K.M. Gamma-hydroxybutyric acid. N. Engl. J. Med. 2005, 352:2721-2732.
35. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 2003, 37:353-357.